The costs of Crohn's disease in the United States and other Western countries: a systematic review

References

• Armitage E, Drummond HE, Wilson DC, et al. Increasing incidence of both juvenile-onset Crohn’s disease and ulcerative colitis in Scotland. Eur J Gastroenterol Hepatol 2001;13:1439–47
   PubMed Web of Science ®Google Scholar
• Fonager K, Sorensen HT, Olsen J. Change in incidence of Crohn’s disease and ulcerative colitis in Denmark: a study based on the National Registry of Patients, 1981–1992. Int J Epidemiol 1997;26: 1003–8
   Google Scholar
• Lapidus A, Bernell O, Hellers G, et al. Incidence of Crohn’s disease in Stockholm County 1955–1989. Gut 1997;41: 480–6
   PubMed Web of Science ®Google Scholar
• Makharia GK. Rising incidence and prevalence of Crohn’s disease in Asia: is it apparent or real? J Gastroenterol Hepatol 2006;21:929–31
   PubMed Web of Science ®Google Scholar
• Yao T, Matsui T, Hiwatashi N. Crohn’s disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum 2000;43:S85–93
   PubMed Web of Science ®Google Scholar
• Loftus Jr EV, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn’s disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther 2002;16:51–60
   Google Scholar
• Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504–17
   PubMed Web of Science ®Google Scholar
• Rubin G, Hungin A, Kelly P, Ling J. Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther 2000;14:1553–9
   PubMed Web of Science ®Google Scholar
• Travis SP./person-group>. Review article: insurance risks for patients with ulcerative colitis or Crohn’s disease. Aliment Pharmacol Ther 1997;11:51–9
   PubMed Web of Science ®Google Scholar
• Canavan C, Abrams KR, Mayberry JF. Meta-analysis: mortality in Crohn’s disease. Aliment Pharmacol Ther 2007;25:861–70
   PubMed Web of Science ®Google Scholar
• Vermeire S, Van Assche G, Rutgeerts P. Altering the natural history of Crohn’s disease: evidence for and against current therapies. Aliment Pharmacol Ther 2007;25:3–12
   PubMed Web of Science ®Google Scholar
• Cohen R. The cost of Crohn’s disease: drugs or surgery? Biodrugs 2000;14:331–44
   PubMed Web of Science ®Google Scholar
• United States Bureau of Labor Statistics./person-group>. Consumer price index: current series. Available at: http://data.bls.gov/PDQ/servlet/SurveyOutputServlet;jsessionid=f030c8cdf7a0$3F$3F$3 [Last accessed 26 September 2007]
   Google Scholar
• Martin A, Gurrieri G, Sturniolo GC, et al. Follow-up of ulcerative colitis, Crohn’s disease, gallstones and chronic active liver disease: analysis of costs. Ital J Gastroenterol 1985;17:11–13
   Google Scholar
• European Central Bank./person-group>. Fixed euro conversion rates. Available at: http://www.ecb.int/bc/intro/html/index.en.html [Last accessed 6 September 2007]
   Google Scholar
• Hay JW, Hay AR. Inflammatory bowel disease: costs-of-illness. J Clin Gastroenterol 1992;14:309–17
   PubMed Web of Science ®Google Scholar
• Feagan BG, Vreeland MG, Larson LR, et al. Annual cost of care for Crohn’s disease: a payor perspective. Am J Gastroenterol 2000;95:1955–60
   PubMed Web of Science ®Google Scholar
• Hay AR, Hay JW. Inflammatory bowel disease: medical cost algorithms. J Clin Gastroenterol 1992;14:318–27
   PubMed Web of Science ®Google Scholar
• Levy RL, Von KM, Whitehead WE, et al. Costs of care for irritable bowel syndrome patients in a health maintenance organization. Am J Gastroenterol 2001;96:3122–9
   PubMed Web of Science ®Google Scholar
• Bassi A, Dodd S, Williamson P, et al. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut 2004;53:1471–8
   PubMed Web of Science ®Google Scholar
• Stark R, Konig HH, Leidl R. Costs of inflammatory bowel disease in Germany. Pharmacoeconomics 2006;24:797–814
   Google Scholar
• Pinchbeck BR, Kierdeikis J, Thomson ABR. Economic impact of inflammatory bowel disease in Alberta. Can J Gastroenterol 1988;2:53–6
   Google Scholar
• Odes S, Vardi H, Friger M, et al. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterol 2006;131:719–28
   PubMed Web of Science ®Google Scholar
• Ebinger M, Leidl R, Thomas S, et al. Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital. J Gastroenterol Hepatol 2004;19:192–9
   PubMed Web of Science ®Google Scholar
• Juan J, Estiarte R, Colome E, et al. Burden of illness of Crohn’s disease in Spain. Dig Liver Dis 2003;35:853–61
   PubMedGoogle Scholar
• Silverstein MD, Loftus EV, Sandborn WJ, et al. Clinical course and costs of care for Crohn’s disease: Markov model analysis of a population-based cohort. Gastroenterology 1999;117:49–57
   PubMed Web of Science ®Google Scholar
• Cohen RD, Larson LR, Roth JM, et al. The cost of hospitalization in Crohn’s disease. Am J Gastroenterol 2000;95:524–30
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Papineau N, Zajaczkowski J, et al. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital. Am J Gastroenterol 2000;95:677–83
   PubMed Web of Science ®Google Scholar
• Rice DP. Estimating the costs of illness. Health Economics Series No. 6. Washington, DC: US Public Health Service; 1966.
   Google Scholar
• American Gastroenterological Association./person-group>. The burden of gastrointestinal diseases. Bethesda, MD: American Gastroenterological Association; 2001.
   Google Scholar
• Longobardi T, Jacobs P, Bernstein CN. Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview Survey. Am J Gastroenterol 2003;98:1064–72
   Google Scholar
• Ferguson A, Sedgwick DM, Drummond J. Morbidity of juvenile onset inflammatory bowel disease: effects on education and employment in early adult life. Gut 1994;35:665–8
   Google Scholar
• Williams JP, Meyers JA. Immune-mediated inflammatory disorders (I.M.I.D.s): the economic and clinical costs. Am J Manag Care 2002;8:S664–81
   PubMed Web of Science ®Google Scholar
• Blomqvist P, Ekbom A. Inflammatory bowel diseases: health care and costs in Sweden in 1994. Scand J Gastroenterol 1997;32:1134–9
   PubMed Web of Science ®Google Scholar
• Longobardi T, Jacobs P, Wu L. Work losses related to inflammatory bowel disease in Canada: results from a national population health survey. Am J Gastroenterol 2003;98:844–9
   Google Scholar
• US Census Bureau./person-group>. State and country quickfacts. Accessed 4 Sept 2007. Available at: http://quickfacts.census.gov/qfd/states/06000.html [Last accessed 4 September 2007]
   Google Scholar
• Eurostat. Total population as of 01.01.06. Available at: http://epp.eurostat.ec.europa.eu/ [Last accessed 12 November 2006]
   Google Scholar
• Munkholm P, Langholz E, Nielsen OH, et al. Incidence and prevalence of Crohn’s disease in the county of Copenhagen, 1962–1887: a sixfold increase in incidence. Scand J Gastroenterol 1992;27:609–14
   PubMed Web of Science ®Google Scholar